Daniel Kahneman and Gary Gottlieb Join Elysium

Welcome to the eighth edition of the Elysium Health monthly newsletter.
This month: We welcome two new board members, our co-founder Leonard Guarente and Scientific Advisory Board member Sir Richard Roberts are interviewed by TIME magazine, and we explain "citizen science" in Endpoints.

Follow us for real-time updates from Elysium.

Daniel Kahneman Joins Scientific Advisory Board "I'm committed to taking Basis and I plan to take it indefinitely."
"It's entirely the people who I have met that excite me about Elysium Health, especially the Scientific Advisory Board."
We are thrilled to welcome Daniel Kahneman to our Scientific Advisory Board. Kahneman is a professor of psychology and public affairs emeritus at the Woodrow Wilson School, the Eugene Higgins Professor of Psychology Emeritus at Princeton University, and a fellow of the Center for Rationality at the Hebrew University in Jerusalem.

He is renowned for his work at the intersection of economics and psychology, particularly in the areas of judgment and decision-making, for which he won the Nobel Prize in Economic Sciences in 2002. This work paved the way for a discipline recognized today as behavioral economics, the study of how people make economic decisions, accounting for predictable human errors and biases.

Professor Kahneman is also author of Thinking, Fast and Slow, selected as a bestseller by The New York Times and a 2012 winner of the National Academy of Sciences Best Book Award.

Kahneman joins a network of more than two dozen world-renowned researchers and clinicians, including seven other Nobel Prize-winning scientists, who guide the direction of Elysium. For more on Kahneman's work, watch this TED Talk in which he explains how our "experiencing selves" and our "remembering selves" perceive happiness differently.

"I attended my first Scientific Advisory Board meeting a few months ago and was enormously impressed."

Gary Gottlieb Joins Elysium's Board

This month, we extend a warm welcome to the newest member of our Board of Directors, Gary L. Gottlieb, professor of psychiatry at Harvard Medical School and CEO of Partners in Health, a global non-profit organization dedicated to bringing modern medicine to the world's poorest communities. He is also a member of the National Academy of Medicine and is chair of the Board of Directors of the Federal Reserve Bank of Boston.

Before joining Partners in Health, Dr. Gottlieb served as president and CEO of Partners HealthCare System, the parent of the Massachusetts General Hospital and Brigham and Women's Hospital, the largest health system in New England, and one of the nation's largest biomedical research and training enterprises. Prior to that, he was president of Boston's prestigious Brigham and Women's Hospital. Gottlieb is a geriatric psychiatrist who established the University of Pennsylvania Medical Center's first program in geriatric psychiatry and developed it into a nationally recognized research, training, and clinical program.

As a member of our board, Gottlieb joins two other non-executive board members, Jim Manzi, chairman of Thermo Fisher Scientific Inc., and David Fialkow, co-founder of General Catalyst. "I hope that what I have learned from the gift of working with wonderful patients and their families, exceptional clinicians and managers, and brilliant scientists can help Elysium to more effectively translate great science into treatments that can help to improve the lives of many people, very safely and effectively," Gottlieb says.

TIME Magazine Profiles NAD+ and Elysium

TIME magazine reports on Elysium and the science of NAD+ in its new longevity issue. Scientists have yet to find a real longevity elixir, the author writes, but a “group of researchers believe they’re getting closer, however, thanks to a compound called nicotinamide adenine dinucleotide, or NAD+ for short.” The story includes interviews with Elysium's chief scientist, Leonard Guarente, and Scientific Advisory Board member, Sir Richard Roberts.
"Leonard Guarente, Elysium’s chief scientist and co-founder–who also directs the Glenn Center for Biology of Aging Research at MIT–says Basis is not intended to extend people’s life spans, but to help them stay healthier for longer."

Books to Read This Winter, Animals That Defy “Normal” Aging, and More

Looking for the best in science writing, or a way to contribute to science without having to step foot in a lab? Read these new stories on Endpoints, Elysium's science journal:

Where Do Your Keep Your Basis?

Our customers come from all walks of life — 10 percent are doctors, others are scientists, artists, and entrepreneurs — but they all make Basis a part of their daily routine. Whether it's on your kitchen counter, in your workspace, or with your gym gear, we'd love to see where Basis fits into your life. For a chance to be featured here and on social, just snap a photo and post it. Here’s how:

For a chance to be featured
Upload a photo on Instagram or Twitter that shows your bottle of Basis.
Tag your photo #BasisForLife and @Elysium_Health on Instagram or @ElysiumHQ on Twitter.
The One Daily Supplement Your Cells Need
Living better means being proactive in taking care of yourself now. Science makes better possible. Through Basis, you can start taking care of your health by supporting your cells.
Plans start at $1.32 per day.

© 2017 Elysium Health Inc., P.O. Box 923, New York, NY 10013
Contact us: (888) 220-6436 or care@elysiumhealth.com

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease, and is intended for healthy adults, 18 years of age or older. Do not take this product if you are pregnant or nursing.